US 12,409,199 B2
Methods of treating endometriosis and other noncancer gynecological disorders with hemp extract
Alexandra M. Capano, Philadelphia, PA (US); Pradeep Singh Tanwar, Fletcher (AU); and Alex Nance, Georgetown, KY (US)
Assigned to Ecofibre USA Inc., Georgetown, KY (US); and The University of Newcastle, Callaghan (AU)
Filed by Ecofibre USA Inc., Georgetown, KY (US); and The University of Newcastle, Callaghan (AU)
Filed on Apr. 18, 2024, as Appl. No. 18/639,285.
Application 18/639,285 is a division of application No. 18/299,810, filed on Apr. 13, 2023, granted, now 11,986,505.
Application 18/299,810 is a division of application No. 18/050,023, filed on Oct. 26, 2022, granted, now 11,654,172, issued on May 23, 2023.
Claims priority of provisional application 63/263,022, filed on Oct. 26, 2021.
Claims priority of provisional application 63/263,020, filed on Oct. 26, 2021.
Claims priority of provisional application 63/263,026, filed on Oct. 26, 2021.
Prior Publication US 2024/0261355 A1, Aug. 8, 2024
Int. Cl. A61K 36/00 (2006.01); A61K 31/015 (2006.01); A61K 31/045 (2006.01); A61K 31/05 (2006.01); A61K 31/352 (2006.01); A61K 31/353 (2006.01); A61K 31/60 (2006.01); A61K 36/185 (2006.01); A61P 35/00 (2006.01)
CPC A61K 36/185 (2013.01) [A61K 31/015 (2013.01); A61K 31/045 (2013.01); A61K 31/05 (2013.01); A61K 31/352 (2013.01); A61K 31/353 (2013.01); A61K 31/60 (2013.01); A61P 35/00 (2018.01)] 11 Claims
 
1. A method of treating endometriosis, symptoms associated with endometriosis, or both, the method comprising administering an effective amount of a composition to a patient, said composition comprising a carrier of between 1% and 99% by weight, said composition comprising a cannabis extract (CE) wherein the CE comprises cannabidiol (CBD) from about 20% to about 99.9% by weight of the CE, the CBD extracted from a Cannabaceae plant as a full spectrum hemp extract (FSHE) or a broad spectrum hemp extract (BSHE), said CE delivered within the carrier to create the composition having a pH between 3.5 and 6.